Paul Alfieri, MD
Cardiovascular Disease · Kennett Square, PANPI 1821032327
Payments from drug & device makers
Across 187 payments — averaging $1416.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lantheus Medical Imaging, Inc.$203K
- GE HealthCare$45K
- Novartis$13K
- Abbott$2K
- Amgen$411
- Johnson & Johnson$269
- plus $1K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lantheus Medical Imaging, Inc. | 20 | $202,837 |
| GE HealthCare | 8 | $45,214 |
| Novartis | 43 | $12,643 |
| Abbott | 2 | $2,052 |
| Amgen | 25 | $411 |
| Johnson & Johnson | 16 | $269 |
| Scpharmaceuticals Inc. | 7 | $192 |
| AstraZeneca | 10 | $180 |
| Novo Nordisk | 11 | $135 |
| Sanofi-aventis U.S. LLC | 6 | $120 |
| Pfizer | 6 | $110 |
| Boehringer Ingelheim | 7 | $105 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $105 |
| Boston Scientific | 4 | $68 |
| Lexicon Pharmaceuticals, Inc. | 2 | $67 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| E.r. Squibb & Sons, L.L.C. | 2 | $46 |
| Kowa Pharmaceuticals America, Inc. | 3 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| Edwards Lifesciences | 1 | $30 |
| Esperion Therapeutics, Inc. | 1 | $30 |
| Heartflow, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $17 |
| Preventice Services, LLC | 1 | $13 |
| Lundbeck LLC | 1 | $13 |
How this compares
$264,836 in reported general payments places this provider in the 95th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Kennett Square
- Danielle DuffyPhiladelphia$29.5M
- Venkatesh NadarCamp Hill$18.3M
- Hemal GadaWormleysburg$6.7M
- Brian DrachmanPhiladelphia$3.8M
- William BachinskyMechanicsburg$2.3M
- Bonnie KyPhiladelphia$1.9M
- Benjamin KalsmithPgh$1.7M
- Marielle Scherrer CrosbiePhiladelphia$1.6M
- Paul GrenaYardley$1.6M
- Peter KoweyWynnewood$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.